Amplia Therapeutics Limited

ASX:ATX.AX

0.15 (AUD) • At close October 23, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Omzet 2.0042.448-0.581.7691.2210.7630.6740.860.0340-00.051-0.0770.6570.6161.1821.4470.817-0.0150.0080.0150000000
Kosten van de omzet 0.3310.0430.0440.0290.0020.00200000.0790.0770.0220.080.0750.1310.1140.1360.14900.0890000000
Brutowinst 1.6742.405-0.6241.741.2190.7610.6730.860.034-0-0.079-0.026-0.10.5770.5411.0511.3320.681-0.1640.008-0.0740000000
Brutowinstmarge 0.8350.9821.0770.9840.9990.9980.99910.9880187.19-0.5111.2910.8780.8790.8890.9210.83411.071-4.9970000000
Onderzoek- en ontwikkelingskosten 3.6112.1941.1583.5292.4711.3021.4610.750.7580.3130.5420.1361.1962.0293.1482.8883.3051.4421.2270.510.6740.1620.1620.1620000
Algemene en administratieve kosten 1.3891.2151.2050.9930.9040.7320.6340.5010.4060.4530.3940.4670.5380.8150.7310.7330.6280.6190.9230.40.50.4370.4370.4370000
Verkoop- en marketingkosten 0.040.1580.3880.1280.1650.050.3510.1770.2050.1220.1470.0970.0340.1580.1440.1530.1420.1290.1400.0160000000
Verkoop-, algemene en administratieve kosten 1.4291.3731.5941.1211.0690.7820.9850.6780.6110.5750.5410.5640.5751.0451.0491.6410.8520.8951.225-0.4510.516-0.107-0.107-0.1070000
Overige kosten -0.023000000000000000000000000000
Bedrijfskosten 5.0163.5672.7524.653.542.0842.4461.4281.370.8891.0840.7011.7133.0894.1834.5474.1772.8543.2040.0591.9560.0550.0550.0550000
Bedrijfsresultaat -3.342-3.61-2.796-4.679-3.542-2.085-2.446-1.429-1.37-0.889-1.163-0.727-1.813-2.512-3.642-3.496-2.844-2.173-3.368-1.35-2.03-1.022-1.022-1.0220000
Bedrijfsresultaat ratio -1.668-1.4744.822-2.644-2.901-2.735-3.632-1.661-40.03202,756.372-14.28523.517-3.821-5.914-2.957-1.966-2.661227.399-178.107-137.0520000000
Totaal overige inkomsten en kosten netto -0.0320.0320.0460.039-0.00100.0030.0570.0020.0040.0110.0090.0110.0160.0480.0130.0360.0380.070.040.092-0.102-0.102-0.1020000
Inkomen voor belasting -3.374-3.578-2.751-4.64-3.542-2.085-2.444-1.371-1.368-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-3.299-1.309-1.938-1.124-1.124-1.1240000
Inkomen voor belasting ratio -1.683-1.4614.743-2.622-2.902-2.735-3.628-1.594-39.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615222.691-172.773-130.8450000000
Belastingkosten -1.989-2.4480.58-1.728-1.221-0.763-0.674-0.86-0.034-0000000000.040.040.0220.0220.0220.0220000
Nettowinst -3.374-1.129-3.331-2.912-2.322-1.323-1.77-0.511-1.334-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-3.299-1.309-1.938-1.124-1.124-1.1240000
Nettowinstmarge -1.683-0.4615.743-1.646-1.902-1.735-2.628-0.594-38.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615222.691-172.773-130.8450000000
WPA (Winst Per Aandeel) -0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.19-0.069-0.11-0.087-0.087-0.0870000
Verwaterde WPA -0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.19-0.069-0.11-0.087-0.087-0.0870000
EBITDA -3.441-3.567-2.752-4.65-3.54-2.084-2.446-1.428-1.37-0.889-1.162-0.726-1.808-2.496-3.622-3.478-2.793-1.656-2.586-0.922-1.264-0.632-0.632-0.6320000
EBITDA ratio -1.717-1.4574.746-2.628-2.9-2.733-3.631-1.661-40.0202,754.488-14.26923.454-3.797-5.882-2.942-1.93-2.028174.575-121.69-85.3470000000